IGF::OT::IGF SMARTT PHARMACOLOGY AND TOXICOLOGY CENTER (PTC); BASE PERIOD; FY16; AMT $1,653,316; CAN 8470205

IGF::OT::IGF SMARTT 药理学和毒理学中心 (PTC)；

• 批准号: 9365901
• 负责人: KATHRYN BAUGHMAN
• 金额: $ 165.33万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-03-01 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9365901
• 关键词: Address; Disease; Family health status; Fostering; Government Agencies; Health; Health Professional; Heart Diseases; Hematological Disease; Individual; Industry; Institutes; Institution; International; Leadership; Life; Lung diseases; Mentors; National Heart, Lung, and Blood Institute; Patients; Pharmacology and Toxicology; Physicians; Prevention; Professional Organizations; Public Health; Research; Research Infrastructure; Research Training; Resources; Scientist; Training; Training and Education; Translations; base; clinical practice; community organizations; patient advocacy group; programs

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.

美国国家心肺和血液研究所(NHLBI)为一个研究、培训和教育项目提供全球领导，以促进心肺和血液疾病的预防和治疗，并增强所有人的健康，使他们能够活得更长、更有成就感。